Magnetic resonance imaging to evaluate NASHA/Dx gel (Zuidex™) for stress urinary incontinence

International Journal of Clinical Practice

Volumn 60, Issue 10, 2006, Pages 1181-1186

  Fianu Jonasson, Aino ^a   Edwall, L ^a   Wiberg, M Kristoffersen ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Female; Magnetic resonance imaging; NASHA Dx gel; Non animal stabilised hyaluronic acid; Urinary incontinence, stress; Zuidex

Indexed keywords

DEXTRANOMER; HYALURONIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; ENDOSCOPY; FEMALE; GEL; GUIDED IMAGERY; HUMAN; IMAGING SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIODIAGNOSTIC EQUIPMENT AND SUPPLIES; STATISTICAL SIGNIFICANCE; STRESS INCONTINENCE; URETHRA; UROLOGICAL PROCEDURES;

ADULT; AGED; DEXTRANS; DRUG EVALUATION; FEMALE; GELS; HUMANS; HYALURONIC ACID; MIDDLE AGED; TREATMENT OUTCOME; URINARY INCONTINENCE, STRESS;

EID: 33748577637     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01056.x     Document Type: Article

References (23)

1. Nygaard IE, Lemke JH. Urinary incontinence in rural older women: prevalence, incidence and remission. J Am Geriatr Soc 1996; 44: 1049-54.
2. Van Kerrebroeck P, Ter Meulen F, Farrelly E, Larsson G, Edwall L, Fianu-Jonasson A. Treatment of stress urinary incontinence: Recent developments in the role of urethral injection. Urol Res 2003; 30: 356-62.
3. Koyama W, Koyanagi A, Mihara S et.al. Prevalence and conditions of urinary incontinence among the elderly. Methods Inf Med 1998; 37: 151-5.
4. Ushiroyama T, Ikeda A, Ueki M. Prevalence, incidence, and awareness in the treatment of menopausal urinary incontinence. Maturitas 1999; 33: 127-32.
5. Bent AE, Foote J, Siegel S, Faerber G, Chao R, Gormley EA. Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol 2001; 166: 1354-7.
6. Herschorn S, Glazer AA. Early experience with small volume periurethral polytetrafluoroethylene for female stress urinary incontinence. J Urol 2000; 163: 1838-42.
7. Lightner DJ. Review of the available urethral bulking agents. Curr Opin Urol 2002; 12: 333-8.
8. Benshushan A, Brzezinski A, Shoshani O, Rojansky N. Periurethral injection for the treatment of urinary incontinence. Obstet Gynecol Surv 1998; 53: 383-8.
9. Hatanaka S, Oneda S, Okazaki K et.al. Induction of malignant fibrous histiocytoma in female Fisher rats by implantation of cyanoacrylate, zirconia, polyvinyl chloride or silicone. In Vivo 1993; 7: 111-5.
10. Malizia AA Jr, Reiman HM, Myers RP et.al. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 1984; 251: 3277-81.
11. Herschorn S, Radomski SB. Collagen injections for genuine stress urinary incontinence: Patient selection and durability. Int Urogynecol J Pelvic Floor Dysfunct 1997; 8: 18-24.
12. Stenberg A, Larsson E, Lackgren G. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: Histological findings. J Urol 2003; 169: 1109-13.
13. Stenberg AM, Sundin A, Larsson BS, Lackgren G, Stenberg A. Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder. J Urol 1997; 158: 1937-41.
14. Lackgren G, Wahlin N, Stenberg A. Endoscopic treatment of children with vesico-ureteric reflux. Acta Paediatr Suppl 1999; 88: 62-71.
15. Stenberg AM, Larsson E, Lindholm A, Ronneus B, Lackgren G. Injectable dextranomer-based implant: Histopathology, volume changes and DNA-analysis. Scand J Urol Nephrol 1999; 33: 355-61.
16. van Kerrebroeck P, ter Meulen F, Larsson G, Farrelly E, Edwall L, Fianu-Jonasson A. Efficacy and safety of a novel system (NASHA/Dx copolymer via the Implacer device) for the treatment of SUI. Urology 2004; 64: 276-81.
17. Carr LK, Herschorn S, Leonhardt C. Magnetic resonance imaging after intraurethral collagen injected for stress urinary incontinence. J Urol 1996; 155: 1253-5.
18. Arbtiani W, Andersen JT, Gajewski JB et.al. Imaging and other investigations. In: Abrams P, Cardozo L, Khoury S, Wein A, eds. Incontinence, 2nd edn. Plymouth, United Kingdom: Health Publication Ltd., pp. 427-47.
19. Kirsch AJ, Perez-Brayfield MR, Scherz HC. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/ hyaluronic acid copolymer: The Children's Hospitals of Atlanta experience. J Urol 2003; 170: 211-5.
20. Robinson D, Anders K, Cardozo L et.al. What do women want? Interpretation of the concept of cure. J Pelvic Surg Med 2003; 9: 273-7.
21. Herschorn S. Current status of injectable agents for female stress urinary incontinence. Can J Urol 2001; 8: 1281-9.
22. Stenberg AM, Larsson G, Johnson P. Urethral injection for stress urinary incontinence: Long-term results with dextranomer/hyaluronic acid copolymer. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14: 335-8.
23. Stenberg AM, Larsson G, Johnson P, Heimer G, Ulmsten U. DiHA Dextran Copolymer, a new biocompatible material for endoscopic treatment of stress incontinent women. Short-term results. Acta Obstet Gynecol Scand 1999; 78: 436-42.